E-cadherin expression in urothelial carcinoma in situ, superficial papillary transitional cell carcinoma, and invasive transitional cell carcinoma
- 1 October 2002
- journal article
- research article
- Published by Elsevier in Human Pathology
- Vol. 33 (10) , 996-1000
- https://doi.org/10.1053/hupa.2002.127441
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- E-cadherin expression predicts clinical outcome in carcinoma in situ of the urinary bladderUrology, 2001
- Urothelial Neoplasia: A Diagnostic ApproachPathology Case Reviews, 2000
- The World Health Organization/International Society of Urological Pathology Consensus Classification of Urothelial (Transitional Cell) Neoplasms of the Urinary BladderThe American Journal of Surgical Pathology, 1998
- Decreased expression of the intercellular adhesion molecule E-cadherin in prostate cancer: Biological significance and clinical implicationsCancer and Metastasis Reviews, 1993
- Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor roleCell, 1991
- E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells.The Journal of cell biology, 1991
- Cadherin Cell Adhesion Receptors as a Morphogenetic RegulatorScience, 1991
- Characterization and chromosomal localization of the gene encoding the human cell adhesion molecule uvomorulinDifferentiation, 1988
- Mapping of the urinary bladder: Its impact on the concepts of bladder cancerHuman Pathology, 1979
- Non-Invasive Papillary Carcinoma of the Bladder Associated with Carcinoma in SituJournal of Urology, 1976